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Abstract Objective: To investigate
whether microdialysis is capable of
assessing metabolic derangements
during intra-abdominal hypertension
(IAH), and whether monitoring of the
rectus abdominis muscle (RAM) by
microdialysis represents a reliable ap-
proach in the early detection of organ
dysfunctions in abdominal compart-
ment syndrome (ACS). Design:
Prospective, randomized, controlled
animal study. Setting: University an-
imal research facility. Subjects:
Fifteen isoflurane-anesthetized
and mechanically ventilated
Sprague–Dawley rats. Interventions:
IAH of 20 mmHg was induced for
3 h and followed by decompression
and reperfusion for another 3-h period
(n = 10). Five sham-operated animals
served as controls. Microdialysis was
performed in the anterior gastric wall,
liver, kidney, and RAM. The anterior
cervical muscles served as distant ref-
erence. Glucose, lactate, pyruvate, and
glycerol was analyzed throughout the
6-h experiment. Measurements and
main results: Prolonged IAH induced
significant cardiopulmonary dysfunc-
tion and persistent abdominal organ
injury. Microdialysis revealed a sig-
nificant increase of lactate/pyruvate
and glycerol in kidney, intestine and
liver, indicating ischemia,
energy failure, and cell membrane
damage. In addition, at 3 h IAH glu-
cose was significantly decreased in all
organs studied. The distant reference
did not show any alteration of lac-
tate/pyruvate, glycerol, and glucose
over the entire 6-h observation period.
In contrast to the other organs, micro-
dialysis of the RAM showed an early
and more pronounced increase of
lactate, lactate/pyruvate and glycerol
already at 1 h IAH. It is noteworthy
that lactate, glycerol, and glucose
did not completely recover upon
decompression of IAH. Conclusions:
Our data suggest that continuous
microdialysis in the RAM may rep-
resent a promising tool for early
detecting IAH-induced metabolic
derangements.
Keywords Microdialysis · Compart-
ment syndromes · Rectus abdominis ·
Animal models · Reperfusion
injuries · Abdominal injuries
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Introduction
In 2004 the consensus conference of the World Soci-
ety on Abdominal Compartment Syndrome (WSACS,
www.wsacs.org) defined intra-abdominal hypertension
(IAH) as intra-abdominal pressure (IAP) ≥12 mmHg [1].
The abdominal compartment syndrome (ACS) describes
a condition of IAH ≥20 mmHg in combination with single
or multiple organ dysfunction which was not previously
present. Recent findings suggest that ACS is associated
with an increased rate of multiple organ dysfunction
syndromes (MODS) [2–5]. Furthermore, ACS has been
identified to be an independent predictor for MODS
and prevention of ACS has been shown to decrease the
incidence of MODS [3, 5].
Prevalence of IAP ≥ 12 mmHg reached more than 50%
and IAP ≥ 20 mmHg was measured in 8% of a mixed gen-
eral adult ICU population during an observation period of
24 h [6]. Still, a significant percentage of intensivists are
unaware of current approaches in diagnosis and manage-
ment of ACS [7]. In a prospective cohort study investi-
gating major torso trauma, ACS developed in 14% of the
study population. Despite good physiological response to
abdominal decompression, the rate of MODS reached 54%
and mortality was 58% [8]. Early detection of impending
ACS may be helpful to lower mortality. Adequate decom-
pression with temporary abdominal closure is effective in
reversing the pathophysiological effects of manifest IAH;
however, this was questioned by Sugrue and coworkers
who demonstrated that reduction of IAP failed to improve
renal function after surgical decompression in 72% of their
patients [9]. The authors concluded that earlier decompres-
sion might have been beneficial for renal function [9].
The crucial development of proinflammatory cytokine-
triggered MODS in ACS may not be influenced by decom-
pression; thus, it appears obvious that early detection and
prevention of impending ACS—before the release of cy-
tokines has occurred—is of pivotal interest in successful
ACS treatment.
Microdialysis has been used in experimental and
clinical settings for monitoring of energy metabolism
in severe brain injury [10], liver transplantation [11],
plastic surgery [12], and cardiovascular surgery [13]. An
increased lactate-to-pyruvate ratio (L/P ratio) has evolved
as a reliable marker for ischemia, and increased glycerol
levels as an indicator for cell membrane damage [14–17].
Recent experimental studies also demonstrate that
intestinal ischemia can successfully be monitored by
microdialysis, placing the catheters into the peritoneal
cavity [18, 19] or the lumen of the gut [20]. It is notewor-
thy that there is no information on whether microdialysis
may be a useful tool to detect metabolic derangements of
intra-abdominal organs during IAH and ACS.
In a previous study, we have demonstrated [21] that the
compartment pressure of the rectus sheath (CPRS) shows
good agreement with IAP in IAH up to 40 mmHg. We
proposed that the rectus sheath can be considered as an
intra-abdominal organ regarding IAH-induced tissue dam-
age, because it is exposed to virtually the same pressure
as the intra-abdominal structures. This finding bears po-
tential clinical relevance, because impending ACS may be
detected earlier by monitoring the metabolism of the rectus
abdominis muscle (RAM) by microdialysis.
The purpose of the present study was to evaluate the
potential of microdialysis to detect intra-abdominal organ
damage in IAH by measuring energy metabolism in liver,
kidney, and intestine. Furthermore, we analyzed the energy
metabolism in the RAM to assess the value and feasibility
of functional RAM monitoring for early detection of im-
pending ACS.
Materials and methods
Animals
Fifteen Sprague–Daley rats [353 ± 29 g body weight
(b. w.)] were used. The animals were kept at 22 °C on
12-h light/dark cycles with free access to tap water and
standard laboratory chow. Experiments were performed in
accordance with the German legislation on protection of
animals and the National Institutes of Health Guide for the
Care and Use of Laboratory Animals.
Anesthesia and hemodynamic monitoring
The animals were anesthetized by breathing isoflurane
(Forene, Abbott, Wiesbaden, Germany). No curarization
was administered. After oral intubation with a 14-G
catheter (Insyte, i. v. Catheter; Vialon, Spain), the animals
were mechanically ventilated with a tidal volume of
1 ml/100 g b. w. The fraction of inspired oxygen was 1.0 to
provide optimal oxygenation. The positive end-expiratory
pressure was set at 1 cm H2O. A baseline respiratory rate
of 60 min–1 was chosen to maintain normoventilation.
The animals were placed on a heating pad to main-
tain body temperature at 37 °C. The right jugular vein and
carotid artery were cannulated for continuous monitoring
of mean arterial pressure (MAP), central venous pressure
(CVP), and heart rate (HR). Throughout the experiment
1 ml/100 g b. w. h–1 saline was substituted.
Surgical procedure
Animals were initially divided into two groups: Animals
of the ACS group underwent anesthesia, intubation,
cannulation, laparotomy, and 3 h of IAH (n = 10). Sham-
operated controls underwent identical procedures without
IAH (n = 5). After midline laparotomy, an intraperitoneal
catheter (12 Ch Redon drain, Dahlhausen, Cologne, Ger-
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many) was placed for fluid instillation and IAP monitoring.
Microdialysis catheters (CMA/20, CMA Microdialysis
AB, Stockholm, Sweden) were placed in the liver, the
left kidney, and the ventral aspect of the gastric wall (see
ESM S.F1). The midline laparotomy was closed with
a running suture, including the peritoneal sheet, all muscle
layers, and the fascia. Another microdialysis catheter was
placed in the RAM before the skin was closed. A fifth
microdialysis catheter was placed in the anterior cervical
muscles (ACM), serving as a distant control.
IAH induction
The model of IAH used in this study has been described
in detail previously [22]. All animals were allowed to sta-
bilize for 30 min before baseline measurements of MAP,
CVP, HR, BCT, and microdialysis sampling. Blood sam-
ples were collected for analysis of arterial blood gases,
blood cell counts, and serum lactate.
Direct continuous measurement of IAP was performed
via the intraperitoneal catheter (see ESM S.F2). The mi-
daxillary line served as zero reference. After baseline anal-
ysis, the IAP was increased to 20 mmHg by instillation
of warmed (40 °C) gelatine polysuccinate (Gelafundin 4%
Infusionsloesung, Braun, Melsungen, Germany). The IAP
was constantly kept at 20 mmHg for 3 h. To decompress
the abdomen, the Gelafundin bag was simply put below
the level of the animal and the intraperitoneal fluid was
allowed to drain back into the bag by gravity. After de-
compression, reperfusion was monitored for an additional
3 h.
Ventilatory and circulatory adaptations were made
to partially compensate for deteriorations during IAH
and reperfusion. An increase in ventilation frequency
(90 min–1) was initiated at the time of IAP increase.
The respiratory rate was further increased to maxi-
mally 100 min–1 according to arterial blood gas analysis
(pCO2 > 60 mmHg). During the first 60 min after de-
compression, a 90 min–1 ventilation frequency allowed
for correction of hypercapnia. The remaining 2 h were
followed by baseline respiratory frequency (60 min–1).
A MAP of 100 mmHg (corresponding with an abdominal
perfusion pressure (APP = MAP-IAP) of 80 mmHg) was
determined as fluid resuscitation endpoint to preserve
adequate abdominal perfusion pressure. When MAP
decreased beyond 100 mmHg, saline substitution was
increased to 2 ml/100g h–1, or, maximally, 4 ml/100g h–1.
Blood sampling
Blood cell counts were analyzed at the beginning and end
of the experiment. Analyses of arterial blood gases and
serum lactate were performed every 60 min. The blood
sampling before and during the experiment resulted in
a total volume of 0.71 ml. At the end of the experiment,
serum analyses additionally included sodium, potassium,
chloride, glucose, aspartate aminotransferase (AST),
alanine aminotransferase (ALT), alkaline phosphatase,
bilirubin, lactate dehydrogenase (LDH), amylase, lipase,
urea, creatinine, creatine kinase (CK), and creatine
kinase-MB (CK-MB) according to standard methods.
Microdialysis
The interstitial concentrations of glucose, lactate, pyru-
vate, and glycerol were assessed as described previously
in detail [23]. The system used in our study included
microprobes (CMA/20, CMA Microdialysis AB, Stock-
holm, Sweden) carrying a microcell that was perfused
by a microinjection pump (CMA/100, CMA Microdial-
ysis AB). The molecular cutoff of the membrane was
20,000 D. The outlet tube was connected to a fraction
collector (CMA/200 F, CMA Microdialysis AB). The
microcell was continuously perfused with a colloid (albu-
min 3%) to reduce fluid loss [24, 25]. The flow rate was
0.8 µl/min for the entire experiment, and microdialysis
samples were collected in 30-min fractions for baseline
measurements followed by 60-min fractions for the 6-h
experimental period. The costs for the microdialysis
equipment reached about 150 Euro per animal.
Statistical analysis
Data are given as mean ± SD. After proving the assump-
tion of normality and equal variance, intergroup com-
parison was performed by unpaired Student’s t-test. For
inner-group comparisons, one-way ANOVA for repeated
measurements and a post-hoc test including the correction
of the alpha-error according to Bonferroni probabilities
were performed. A p-value of < 0.05 was considered
significant.
Results
IAH and reperfusion-induced systemic cardiopulmonary
responses
The IAH of 20 mmHg caused a significant decrease of
MAP not only during IAH, but in particular during reper-
fusion after decompression (Table 1). This decrease was
observed despite a more vigorous fluid resuscitation com-
pared with controls (51 ± 14 vs. 28 ± 0 ml, p < 0.05). The
CVP progressively increased during IAH but rapidly nor-
malized during reperfusion after decompression (Table 1).
It is noteworthy that in controls hematocrit decreased
from 44.0 ± 3.2 to 37.5 ± 3.4% (p < 0.05), whereas
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Table 1 Intra-abdominal hypertension and reperfusion-induced sys-
temic cardiopulmonary responses; BL baseline; MAP mean arterial
pressure; APP abdominal perfusion pressure; FS fluid substitution;
CVP central venous pressure; RR respiratory rate; BE base excess;
ACS acute compartment syndrome animals (n = 10); Sham sham-
operated control animals (n = 5)
Baseline 1 h 2 h 3 h 4 h 5 h 6 h
MAP
(mmHg)
Sham 108 ± 16 108 ± 6 117 ± 16 111 ± 18 107 ± 14 103 ± 11 106 ± 8
ACS 116 ± 10 107 ± 13 105 ± 12 95 ± 19 a 93 ± 16 a 90 ± 14 a 89 ± 17 a,b
APP
(mmHg)
Sham 88 ± 16 88 ± 6 97 ± 16 91 ± 18 87 ± 14 83 ± 11 86 ± 8
ACS 96 ± 10 87 ± 13 85 ± 12 75 ± 19 a 73 ± 16 a 70 ± 14 a 69 ± 17 a,b
FS
(ml/h)
Sham 3.6 ± 0 3.6 ± 0 3.6 ± 0 3.6 ± 0 3.6 ± 0 3.6 ± 0 3.6 ± 0
ACS 3.6 ± 0 5.7 ± 2.8 6.0 ± 2.8 6.0 ± 2.8 6.6 ± 3.5 9.9 ± 3.0 10.2 ± 3.1
CVP
(mmHg)
Sham 3 ± 1 2 ± 1 2 ± 1 2 ± 1 2 ± 1 3 ± 2 2 ± 1
ACS 3 ± 2 6 ± 2 a 7 ± 2 a,b 9 ± 3 a,b 2 ± 1 c 2 ± 1 c 2 ± 1 c
RR
(min−1)
Sham 60 ± 0 60 ± 0 60 ± 0 60 ± 0 60 ± 0 60 ± 0 60 ± 0
ACS 60 ± 0 90 ± 0 90 ± 0 93 ± 4.8 90 ± 0 60 ± 0 60 ± 0
pO2
(mmHg)
Sham 416 ± 61 453 ± 38 415 ± 41 392 ± 48 388 ± 50 415 ± 48 416 ± 50
ACS 396 ± 67 210 ± 76 a,b 131 ± 49 a,b 93 ± 15 a,b 209 ± 88 a,b,c 212 ± 67 a,b,c 200 ± 67 a,b,c
pCO2
(mmHg)
Sham 34 ± 7 35 ± 4 34 ± 7 38 ± 7 34 ± 4 36 ± 5 40 ± 5
ACS 31 ± 5 39 ± 8 49 ± 11 a,b 65 ± 10 a,b 33 ± 7 c 39 ± 7 c 40 ± 5 c
pH
Sham 7.48 ± 0.03 7.42 ± 0.05 7.41 ± 0.05 7.40 ± 0.04 7.42 ± 0.02 7.43 ± 0.03 7.42 ± 0.02
ACS 7.49 ± 0.04 7.26 ± 0.05 a,b 7.14 ± 0.08 a,b 6.99 ± 0.08 a,b 7.22 ± 0.09 a,b,c 7.18 ± 0.08 a,c 7.17 ± 0.09 a,b,c
BE
(mmol/l)
Sham 0.5 ± 3.9 –2.0 ± 3.6 –3.5 ± 1.5 –2.1 ± 3.4 –2.6 ± 2.2 –1.5 ± 2.3 0.5 ± 3.0
ACS –0.8 ± 4.9 –9.9 ± 3.2 a,b –13.2 ± 2.8 a,b –16.1 ± 3.0 a,b –14.1 ± 4.7 a,b –14.3 ± 4.1 a,b –14.6 ± 3.2 a,b
Lactate
(mmol/l)
Sham 2.6 ± 0.2 2.3 ± 0.3 2.4 ± 0.7 2.1 ± 0.9 1.8 ± 0.9 1.6 ± 0.5 a 1.7 ± 0.5 a
ACS 2.3 ± 0.6 2.0 ± 0.6 2.3 ± 0.5 3.2 ± 0.7 a,b 2.6 ± 0.5 b,c 1.9 ± 0.4 c 2.6 ± 0.3 b,c
Data are given as mean ± SD; a p < 0.05 vs. baseline; b p < 0.05 vs. sham; c p < 0.05 vs. 3 h
Parameter ACS Sham Significance ( p)
Na (mmol/l) 141.6 ± 2.3 141.7 ± 1.2 0.937
K (mmol/l) 5.0 ± 0.8 4.5 ± 0.4 0.224
Cl (mmol/l) 116.9 ± 4.6 109.2 ± 3.3 0.011
Glucose (mg/dl) 97.9 ± 31.5 153.7 ± 17.2 0.015
AST (U/l) 220.7 ± 91.3 97.0 ± 33.6 0.026
Bilirubin (mg/dl) 0.15 ± 0.08 0.09 ± 0.04 0.255
LDH (U/l) 400.7 ± 202.1 108.0 ± 58.2 0.016
Urea (mg/dl) 76.1 ± 15.7 36.9 ± 7.4 0.002
Creatinine (mg/dl) 0.39 ± 0.15 0.19 ± 0.02 0.047
Data are given as mean ± SD; Blood samples were collected after 3 h IAH and 3 h reperfusion after
abdominal decompression
Table 2 Intra-abdominal
hypertension and
reperfusion-induced organ
injury; ACS abdominal
compartment syndrome animals
(n = 10); Sham sham-operated
control animals (n = 5); AST
aspartate aminotransferase; LDH
lactate dehydrogenase
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Fig. 1 The L/P ratio in the
anterior cervical muscles
(a, serving as distant reference);
the rectus abdominis muscle (b);
as well as the gastric wall (c);
the liver (d); and the kidney (e);
during baseline (base); 3 h of
IAH (1 h, 2 h, 3 h), and 3 h of
reperfusion after abdominal
decompression (4 h, 5 h, 6 h);
Data are given as
means ± standard deviations;
* p < 0.05 vs. baseline; § p < 0.05
vs. 3 h, # p < 0.05 vs. reference
(anterior cervical muscles)
no changes were observed in ACS animals (40.5 ± 4.3
vs. 39.6 ± 6.4, p = 0.532). In contrast, in both groups
body weight was found increased at the end of the 6-h
observation period when compared with baseline (ACS:
389 ± 31 vs. 346 ± 33 g, p < 0.05; controls: 380 ± 15 vs.
366 ± 14 g, p < 0.05).
The IAH produced a combined metabolic and respi-
ratory acidosis. A progressive hypercapnia was observed
during IAH, which, however, normalized to baseline levels
immediately after abdominal decompression (Table 1). In
contrast, the pH and the base excess, which were found to
be significantly deteriorated during IAH, did not normalize
after decompression. Serum lactate levels showed a slight
increase during IAH, but normal values during reperfusion
(Table 1).
The PO2 values displayed a mirror image of the pCO2
values, indicating a generalized deterioration of gas ex-
change during IAH (Table 1). After decompression, pO2
did not normalize, most probably due to manifestation of
reperfusion injury with pulmonary edema in combination
with emphysema and atelectasis [18].
IAH and reperfusion-induced organ injury
Analysis of serum AST as an indicator of hepatocellular
injury revealed significantly (p < 0.05) higher values in
ACS animals compared with sham controls (Table 2). The
LDH showed also a fourfold increase after 3 h IAH and
3 h reperfusion. Furthermore, serum urea and creatinine
showed a twofold increase in ACS animals, whereas serum
glucose levels were significantly (p < 0.05) reduced com-
pared with controls (Table 2). Sodium and potassium con-
centrations were not affected by IAH and reperfusion, but
chloride showed a significant (p < 0.05) increase after the
6-h experimental study period (Table 2).
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Fig. 2 Microdialysis of glycerol
concentrations in the anterior
cervical muscles (a, serving as
distant reference); the rectus
abdominis muscle (b); as well as
the gastric wall (c); the liver (d);
and the kidney (e); during
baseline (base); 3 h of IAH (1 h,
2 h, 3 h) and 3 h of reperfusion
after abdominal decompression
(4 h, 5 h, 6 h); Data are given as
means ± standard deviations;
* p < 0.05 vs. baseline; § p < 0.05
vs. 3 h, # p < 0.05 vs reference
(anterior cervical muscles)
IAH and reperfusion-induced alteration of tissue energy
metabolism
Microdialysis analysis of the ACM demonstrated that IAH
and reperfusion after decompression did not affect glucose
(ESM S.F3A), lactate (ESM S.F4A), and glycerol concen-
tration (Fig. 2a) during the entire 6-h observation period.
Accordingly, the L/P ratio remained unchanged (Fig. 1a).
This indicates that IAH and decompression did not affect
energy metabolism in distant tissue.
In liver and gastric wall, analysis of tissue glucose
concentrations revealed a progressive decrease during
IAH compared with baseline (ESM S.F3C/D). Glucose
concentrations in the kidney were only slightly affected
(ESM S.F3E). It is noteworthy that changes of glu-
cose concentrations in the RAM paralleled the changes
observed in the liver and the gastric wall (ESM S.F3B).
Analysis of tissue lactate concentrations revealed an
only slight decrease in the liver and a minor elevation in the
gastric wall during IAH (ESM S.F4C/D). These changes,
however, were in a range of only 25% of baseline. In kid-
ney, no relevant changes could be observed within the en-
tire 6-h observation period (ESM S.F4E). In contrast, in the
RAM lactate concentrations increased progressively dur-
ing IAH and returned toward baseline only at the end of
reperfusion (ESM S.F4B).
In kidney and gastric wall tissue, but in particular in the
liver, analysis of the L/P ratio showed a two- to fivefold in-
crease during IAH, clearly distinguishing local deteriora-
tion of energy metabolism compared with the non-affected
metabolism of the ACM (Fig. 1). The L/P ratio was found
normalized in all tissues at the end of the 3-h reperfusion
after decompression. It is noteworthy that the L/P ratio
in the RAM showed a drastic increase during IAH with
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values tenfold higher than baseline (Fig. 1b). After decom-
pression the L/P ratio of the RAM declined rapidly towards
values measured before IAH.
Accordingly, tissue glycerol concentrations increased
significantly during IAH in liver, kidney, and gastric wall,
but normalized during reperfusion after decompression
(Fig. 2). In the RAM, the increase of glycerol concentra-
tions during IAH was more pronounced compared with
the other tissues, and no complete normalization was
observed during reperfusion (Fig. 2b).
Because the distant reference was also taken from mus-
cle tissue, data obtained from the RAM and the ACM may
be directly compared. The L/P ratio in the RAM was sig-
nificantly higher already after the first hour of IAH (42.2
vs. 11.2, p < 0.01). At 3 h IAH the L/P ratio was elevated
15-fold in the RAM compared with the ACM (157.6 vs.
10.6, p < 0.05). Accordingly, glycerol and lactate concen-
trations were also significantly (p < 0.01) increased in the
RAM compared with the distant reference throughout the
entire 3-h IAH period (Figs. 1, 2; ESM S.F4).
Discussion
The major findings of the present study are that (a)
metabolic derangements of intra-abdominal organs during
IAH of 20 mmHg can be detected by microdialysis, and
(b) deteriorations of the L/P ratio and the glucose, lactate,
and glycerol concentrations in the RAM indicate ACS-
induced intra-abdominal organ dysfunction and injury. As
the increase of ischemia markers (L/P ratio, glycerol) was
early and more pronounced in the RAM compared with
liver, kidney, and intestine, functional RAM monitoring
by microdialysis may be a novel promising tool for early
detection of impending ACS.
The deleterious effect of an increased IAP on the
cardiovascular system, the lung, and various abdominal
organs has been investigated in numerous experimental
and clinical studies, demonstrating increased pulmonary
pressure and hypoxia, decreased cardiac output and
hypotension, as well as acidosis and oliguria [26–28].
Recent investigations showed a strong association be-
tween ACS and manifestation of MODS [29]. Clinical
occult IAH can produce bacterial translocation and
metabolically relevant ischemia of the gut and the
liver [30–32]. Furthermore, the intestine has been invoked
as a cytokine-generating organ after mesenteric ischemia
and reperfusion. In a two-hit model of hemorrhagic
shock and subsequent ACS, massive neutrophil priming
provoked lung and liver injury [3]. Systemic elevation
of interleukin-1 (IL-1), IL-6, IL-8, and tumor necrosis
factor-α concentrations are thought to be the cause for
the activation of the primed circulating neutrophils,
which finally promote development of MODS [2, 4].
To avoid the onset of the “second hit” and thus de-
velopment of MODS, major focus should be placed
on the early recognition of a metabolically critical
IAH.
Limitations of the model
The model demonstrated pathophysiological alterations
consistent with IAH and ACS. During the experiment,
adaptation of fluid administration and ventilation rate have
been made to maintain adequate APP and tissue oxygena-
tion. Despite marked CO2 accumulation during IAH, the
reference in the ACM demonstrated baseline conditions
throughout the experiment; however, microdialysis was
not performed in shams and therefore the study lacks
a true control. Compared with other rodent models which
maintained IAH only up to 60–90 min, metabolic changes
were monitored for 3 h and 3 h of reperfusion in the herein
presented model [2, 3, 22, 31].
Assessment of microcirculation in IAH
Experimental studies have demonstrated that an increase
of IAP to 18–20 mmHg decreases both hepatic arterial
and portal venous blood flow [32, 33]. Furthermore, an
IAP of 25 mmHg results in a decrease of ileal mucosal
blood flow to 63% of baseline values [31]. The analysis of
blood flow may be adequate to indirectly assess metabolic
alterations, as indicated by experiments demonstrating
a strong correlation between superior mesenteric artery
blood flow and mesenteric oxygen delivery with gastric
tissue oxygenation [34]. Nonetheless, microdialysis may
be superior to these indirect techniques, because more de-
tailed information on cell energy metabolism (e. g., lactate
and pyruvate), cell membrane damage (e. g., glycerol), and
microvascular delivery (e. g., glucose) can be achieved.
Herein, we demonstrate for the first time that the use of mi-
crodialysis is effective to indicate metabolic deteriorations
during IAH of 20 mmHg. This is in line with the finding of
others, demonstrating that gastric mucosal acidosis as de-
termined by gastric tonometry can also indicate metabolic
derangements during IAH [35, 36]. Although we did not
perform a comparative study between microdialysis and
gastric tonometry, our results indicate that the RAM is
more susceptible to IAH-induced ischemia than the gastric
wall; thus, microdialysis of the RAM may be preferred to
gastric tonometry for early detection of critical IAH.
Alteration of tissue glucose
In the present study, we observed a decrease in tissue glu-
cose levels during IAH. This is probably due to the locally
impaired blood flow which is associated with a decreased
delivery of glucose [37]. This view is supported by the re-
sults of a previous study, demonstrating with the use of an
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intraperitoneally placed microdialysis catheter a decrease
of glucose concentrations during local gut ischemia [18].
Alteration of tissue lactate
Lactate alone may not be a reliable marker of ischemia,
because hypermetabolism also results in high lactate
levels [16]. In the present study, lactate concentrations in
the gastric wall, the liver, and the kidney were almost not
affected by IAH and reperfusion. In contrast, the RAM
showed a rapid and distinct increase of lactate during IAH.
Although our study did not elucidate the cause of this
differential response, it may be speculated that the local
ischemia was not as severe to induce lactate accumulation
in the intra-abdominal organs, but sufficient to provoke
a significant increase in the RAM. This would further
support the view that monitoring of metabolic changes in
the RAM may be used to detect early deteriorations of an
impending ACS.
Alteration of L/P ratio
The lactate-to-pyruvate (L/P) ratio is a well-known marker
of cell ischemia, indicating an inadequate supply of
oxygen and glucose [14, 15]. In the present study IAH
provoked a significant increase of the L/P ratio in all
organs studied. Nonetheless, the magnitude of the increase
of the L/P ratio markedly differed between the different
tissues. In the RAM, a tenfold increase was observed,
whereas the increase in liver, kidney, and gastric wall
was only two- to fivefold when compared with physio-
logical baseline. This may also reflect that the metabolic
deterioration during 20 mmHg IAH is more pronounced
in the RAM compared with the intra-abdominal organs.
The fact that the L/P ratio did not normalize immediately
after decompression, in particular in muscle and liver,
may indicate maintenance of ischemia due to capillary
no-reflow, as described characteristically in muscle and
hepatic tissue during postischemic reperfusion [38, 39].
This is in line with clinical observations which demon-
strate lack of improvement of individual organ function
after reduction of IAP [9].
Alteration of tissue glycerol
Microdialysis studies from the brain suggest that glycerol
could act as a marker of ischemia, energy failure, and, in
particular, cell membrane damage [16, 17]. The present
study shows for the first time that IAH provokes a signifi-
cant elevation of glycerol concentrations in liver, kidney,
intestine, and muscle. It is noteworthy that the increase of
glycerol concentration was markedly more pronounced in
muscle than in the intra-abdominal organs and was signi-
ficantly protracted in the reperfusion period. This indicates
more pronounced cell damage in the muscle tissue during
both IAH and reperfusion after decompression.
Relevance of RAM in IAH
Diebel and coworkers [40] demonstrated a negative cor-
relation between increasing IAP and reduced abdominal
wall blood flow in a pig model. Despite maintained
cardiac output and MAP, rectus sheath blood flow,
measured by Doppler laser flowmetry, decreased to
45% of baseline values when an IAP of 20 mmHg
was induced; however, the critical level of perfusion
was not evaluated. In a previous study we could show
that the pressure measured in the rectus sheath reflects
the IAP, indicating that RAM pressure measurement
may serve as an alternative to intravesicular or gastric
pressure measurement [21]. The results of the present
study now indicate for the first time that monitoring
of energy metabolism by microdialysis in the RAM
may represent a valuable tool in the early detection of
impending ACS by assessing IAH-induced metabolic
deteriorations.
To distinguish between local and systemic responses
upon induction of IAH, we additionally placed a reference
probe into the distant ACM. This setting allowed not
only the monitoring of systemic metabolic alterations but
also made a direct comparison possible between identical
tissues, e. g., the RAM directly exposed to IAH and the
distant ACM not directly exposed to pressure elevation.
Our data indicate that during early IAH systemic energy
metabolism is not affected, whereas locally the RAM
shows a marked increase of ischemia markers already
within the first hour of pressure elevation. This strongly
supports the view that the RAM is directly influenced by
IAH, and that metabolic deteriorations can effectively be
monitored by microdialysis. The fact that the metabolic
alterations occur early and more pronounced in the RAM
than in the liver, kidney, and gastric wall indicates an even
higher susceptibility to increased IAP.
The IAH is known to decrease local blood flow in the
rectus sheath [40]. In a previous study, we could demon-
strate that compartment pressure in the RAM is basically
similar to the IAP in the presence of IAH [21]. We are not
aware whether similarly increased pressures within the
intra-abdominal space and the rectus sheath lead to differ-
ent alterations of microvascular blood flow with enhanced
deteriorations in the rectus muscle. A more pronounced
decrease of microvascular blood flow in the RAM might
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be an explanation for the more pronounced increase in is-
chemia and cell damage markers. In fact, this explanta-
tion would further support that monitoring of the RAM by
microdialysis would represent an ideal tool for early de-
tection of IAH and ACS. This would be particularly im-
portant in case irreversible injury of the intra-abdominal
organs has not already developed, as demonstrated in the
present study.
Conclusion
Our study shows that deterioration of energy metabolism
in IAH can successfully be monitored by microdialysis.
In combination with routine IAP monitoring, continuous
microdialysis of the rectus abdominis muscle may be
a promising tool for detecting metabolically relevant IAH
in high-risk patients before ACS is clinically apparent.
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